L57.3 Poikiloderma of Civatte

Name of the Condition

• Poikiloderma of Civatte
• ICD Code: L57.3

Summary

Poikiloderma of Civatte is a chronic skin condition characterized by a combination of hyperpigmentation, hypopigmentation, telangiectasia, and mild atrophy, typically affecting sun-exposed areas of the neck and upper chest. It results from cumulative sun damage and is more common in women, often presenting with a reticulated or net-like pattern.

Causes

The condition is primarily caused by chronic exposure to ultraviolet (UV) radiation, particularly from sunlight. Other contributing factors may include hormonal influences, heat, and friction from clothing or accessories. The exact mechanism involves UV-induced damage to skin cells, leading to pigmentary changes and vascular abnormalities.

Risk Factors

• Prolonged or repeated UV exposure (e.g., occupational or recreational).
• Female gender (more common in women).
• Fair skin that burns easily.
• Living in regions with high sun intensity.
• Use of certain cosmetics or fragrances that increase photosensitivity.
• Hormonal changes (e.g., menopause).

Symptoms

• Reticulated (net-like) pattern of hyperpigmentation and hypopigmentation.
• Visible small blood vessels (telangiectasia) on the skin.
• Mild skin thinning or atrophy.
• Occasional itching or mild discomfort.
• Predominant involvement of the neck, upper chest, and sometimes the face.

Diagnosis

Diagnosis is based on a physical examination of the affected areas, focusing on the characteristic pattern of pigmentary changes and telangiectasia. A dermatologist may assess the distribution and history of sun exposure to confirm the diagnosis. In some cases, a biopsy may be performed to rule out other conditions.

Treatment Options

• Topical therapies: Creams or gels containing retinoids, hydroquinone, or azelaic acid to address pigmentation and texture.
• Laser treatments: Vascular lasers to reduce telangiectasia; fractional lasers for skin texture.
• Intense pulsed light (IPL): To target both pigmentation and blood vessels.
• Sun protection: Strict avoidance of UV exposure and use of broad-spectrum sunscreen.

Prognosis and Follow-Up

The condition is chronic and may persist despite treatment. Regular follow-up with a dermatologist is recommended to monitor for changes and adjust therapy. Long-term sun protection is essential to prevent progression or recurrence.

Complications

• Persistent cosmetic concerns due to pigmentation and vascular changes.
• Increased risk of other sun-related skin conditions with ongoing UV exposure.
• Rarely, progression to more severe skin damage if not managed.

Lifestyle & Prevention

• Consistent use of broad-spectrum sunscreen (SPF 30+) on sun-exposed areas.
• Wearing protective clothing (e.g., hats, scarves) to shield the neck and chest.
• Avoiding peak sun hours (10 a.m. to 4 p.m.).
• Limiting exposure to artificial UV sources (e.g., tanning beds).
• Using gentle skincare products to avoid irritation.

When to Seek Professional Help

Consult a dermatologist if you notice new or worsening skin changes, persistent itching, or if the condition does not improve with sun protection and over-the-counter treatments. Early evaluation is important to rule out other skin disorders.

Tips for Medical Coders

When coding for Poikiloderma of Civatte (L57.3), ensure documentation supports the characteristic findings of reticulated pigmentation, telangiectasia, and sun-exposed distribution. Note any associated factors like UV exposure or hormonal influences, as these may impact coding specificity. Verify that the diagnosis aligns with the clinical presentation to avoid miscoding.